US · Healthcare

Catalyst Pharmaceuticals Inc (CPRX)

Biotechnology

Catalyst Pharmaceuticals Inc (CPRX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CPRX

P/E ratio

18.00

Catalyst Pharmaceuticals Inc (CPRX) — FAQ

What is CPRX's P/E ratio?

The price-to-earnings (P/E) ratio for Catalyst Pharmaceuticals Inc (CPRX) is 18.00 (data as of 2026-03-24).

Does Catalyst Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Catalyst Pharmaceuticals Inc (CPRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Catalyst Pharmaceuticals Inc in?

Catalyst Pharmaceuticals Inc (CPRX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CPRX listed on?

CPRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)